إعلان
إعلان
CUE
Cue Biopharma, Inc.
0.36
USDبرعاية
-0.03
-8.63%
٠٩ يناير, ١٥:٥٨ UTC -5
مغلق
بعد الإغلاق
0.37
+0.01
+3.90%
تقارير أرباح CUE
النسبة الإيجابية المفاجئة
CUE تفوق 18 من 29 آخر التقديرات.
62%
التقرير التالي
بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$2.52M
/-$0.10
التغير الضمني من Q3 25 (Revenue/ EPS)
+17.50%
/+42.86%
التغير الضمني من Q4 24 (Revenue/ EPS)
+60.22%
/-23.08%
Cue Biopharma, Inc. earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, CUE reported earnings of -0.07 USD per share (EPS) for Q3 25, beating the estimate of -0.09 USD, resulting in a 25.77% surprise. Revenue reached 2.15 مليون, compared to an expected 2.31 مليون, with a -7.07% difference. The market reacted with a -7.19% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.10 USD, with revenue projected to reach 2.52 مليون USD, implying an زيادة of 42.86% EPS, and زيادة of 17.50% in Revenue from the last quarter.
الأسئلة الشائعة
What were Cue Biopharma, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Cue Biopharma, Inc. reported EPS of -$0.07, beating estimates by 25.77%, and revenue of $2.15M, -7.07% below expectations.
How did the market react to Cue Biopharma, Inc.'s Q3 2025 earnings?
The stock price moved down -7.19%, changed from $0.67 before the earnings release to $0.62 the day after.
When is Cue Biopharma, Inc. expected to report next?
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
What are the forecasts for Cue Biopharma, Inc.'s next earnings report?
Based on 3
المحللين, Cue Biopharma, Inc. is expected to report EPS of -$0.10 and revenue of $2.52M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان